Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

NCT02206503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Cyclophosphamide
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Fondazione EMN Italy Onlus